Back to Arizona

HB2617 • 2026

insurance; prostate cancer; cost sharing

HB2617 - insurance; prostate cancer; cost sharing

Healthcare
Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Walt Blackman
Last action
2026-03-09
Official status
House committee of the whole
Effective date
Not listed

Plain English Breakdown

The official source material does not specify if there are any limitations on the type of prostate cancer screenings that qualify under this bill, beyond being diagnostic and for high-risk individuals.

Insurance Changes for Prostate Cancer Screenings

This bill stops health insurance companies from requiring high-risk men to pay extra costs for prostate cancer screening tests starting in 2027.

What This Bill Does

  • Prevents health insurers from making high-risk men pay more for prostate cancer screening tests after January 1, 2027.
  • Defines high risk as being at least 40 years old and having certain factors like African ancestry or a family history of prostate cancer.
  • Includes military veterans exposed to Agent Orange in the definition of high-risk individuals.
  • Does not apply to out-of-network screenings where patients go outside their insurance network.

Who It Names or Affects

  • Health insurers who issue, amend, or renew policies after January 1, 2027.
  • High-risk men aged 40 and older with specific risk factors for prostate cancer.

Terms To Know

High-risk
Men aged 40 and older who have African ancestry, carry the BRCA1 or BRCA2 gene, have a family history of prostate cancer, were exposed to Agent Orange as military veterans, or have certain genetic mutations.

Limits and Unknowns

  • The bill does not cover out-of-network screenings.
  • It only applies to health insurers that issue, amend, or renew policies after January 1, 2027.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

Plain English: Adopted 1

  • The official amendment file could not be read automatically during the last sync, so only the official amendment metadata is shown right now.

Plain English: Fifty-seventh Legislature Health & Human Services Second Regular Session H.B.

  • Fifty-seventh Legislature Health & Human Services Second Regular Session H.B.
  • 2617 PROPOSED HOUSE OF REPRESENTATIVES AMENDMENTS TO H.B.
  • 2617 (Reference to printed bill) The bill as proposed to be amended is reprinted as follows: 1 Section 1.
  • Title 20, chapter 4, article 3, Arizona Revised 2 Statutes, is amended by adding section 20-841.14, to read: 3 20-841.14.
  • This amendment summary is using official source text because generated interpretation was skipped for this run.

Plain English: A GRAHAM 3/9/2026 (602) 926-3848 ARIZONA HOUSE OF REPRESENTATIVES FLOOR AMENDMENT EXPLANATION 57th Legislature, 2nd Regular Session Majority Research Staff HB 2617: insurance; prostate cancer; cost sharing BLACKMAN FLOOR AMENDMENT 1.

  • A GRAHAM 3/9/2026 (602) 926-3848 ARIZONA HOUSE OF REPRESENTATIVES FLOOR AMENDMENT EXPLANATION 57th Legislature, 2nd Regular Session Majority Research Staff HB 2617: insurance; prostate cancer; cost sharing BLACKMAN FLOOR AMENDMENT 1.
  • Incorporates the HHS Committee amendment.
  • 2.
  • Clarifies that the prohibition on cost sharing for diagnostic prostate cancer screenings for high -risk subscribers does not apply to out -of-network screenings.
  • This amendment summary is using official source text because generated interpretation was skipped for this run.

Bill History

  1. 2026-03-09 House

    House committee of the whole

  2. 2026-03-03 House

    House minority caucus

  3. 2026-03-03 House

    House majority caucus

  4. 2026-01-26 House

    House second read

  5. 2026-01-22 House

    House Rules: C&P

  6. 2026-01-22 House

    House Health & Human Services: DPA

  7. 2026-01-22 House

    House first read

Official Summary Text

HB2617 - 572R - House Bill Summary

ARIZONA HOUSE OF REPRESENTATIVES

57th
Legislature, 2nd Regular Session

Majority Research Staff

House:
HHS DPA 10-2-0-0

HB
2617
: insurance; prostate cancer; cost sharing

Sponsor:
Representative Blackman, LD 7

House
Engrossed

Overview

Prohibits
health care insurers that issue, amend or renew a policy or contract, beginning
January 1, 2027, from imposing cost sharing requirements for diagnostic
prostate cancer screenings for high-risk subscribers.

History

Health care insurers
include disability insurers, group disability
insurers, blanket disability insurers, health care services organizations,
hospital service corporations and medical service corporations (A.R.S. �
20-1379
).

Laws 2014,
Chapter 255
prohibits an insurance policy, contract or
evidence of coverage, that covers cancer medications that are injected or
intravenously administered by a health care provider and covers
patient-administered cancer medications, from requiring a higher copayment,
deductible, or coinsurance amount for the patient-administered medications than
is required for the provider-administered medications. It allows for an
increase in copayment, deductible or coinsurance amounts for cancer medications
if the increase is applied generally to other medical or pharmaceutical
benefits under the contract, policy or evidence of coverage and is not done to
circumvent the legislation. A health insurer is also prohibited from
reclassifying benefits with respect to cancer treatment medications in a manner
that is inconsistent with this legislation. Cancer treatment medications are
prescriptions drugs and biologics that are used to kill, slow or prevent the
growth of cancerous cells (A.R.S. ��
20-841.10,

20-1057.14
,
20-1376.05

and
20-1406.06
).

Provisions

1.

Prohibits a
health care insurer that issues, amends or renews a contract or policy on or
after January 1, 2027, from imposing cost sharing requirements for diagnostic
prostate cancer screenings for high-risk subscribers. (Sec. 1-4)

1.

Defines
high
risk
as men who are at least 40 years of age and to whom any of the
following applies:

a)

are of
African ancestry;

b)

carry the
breast cancer gene, including the BRCA1 or BRCA2 gene; or

c)

have a
family history of prostate cancer. (Sec. 1-4)

2.

Specifies
that
men who have a family history of prostate cancer
, includes a
first-degree relative who:

a)

was diagnosed with prostate
cancer and under the age of 60 at the time of diagnosis;

b)

died of prostate cancer; or

c)

developed a form of cancer that
is known to be associated with an increased risk of prostate cancer. (Sec. 1-4)

2.

Clarifies
that the prohibition on cost sharing for diagnostic prostate cancer screenings for
high-risk subscribers does not apply to out-of-network screenings. (Sec. 1-4)

---------- DOCUMENT FOOTER ---------

AG/LK����������� HB
2617

3/26/2026������� Page
0 House Engrossed

---------- DOCUMENT FOOTER ---------

Current Bill Text

Read the full stored bill text
HB2617 - 572R - H Ver

House Engrossed

insurance; prostate
cancer; cost sharing

State of Arizona

House of Representatives

Fifty-seventh Legislature

Second Regular Session

2026

HOUSE BILL 2617

AN
ACT

amending title 20, chapter 4, article 3,
arizona revised statutes, by adding section 20-841.14; amending title 20,
chapter 4, article 9, arizona revised statutes, by adding SECTION 20-1057.21;
amending title 20, chapter 6, article 4, arizona revised statutes, by adding
section 20-1376.11; amending title 20, chapter 6, article 5, arizona
revised statutes, by adding section 20-1406.11; relating to health
insurance.

(TEXT OF BILL BEGINS ON NEXT PAGE)

Be it
enacted by the Legislature of the State of Arizona:

Section
1.
1. Title
20, chapter 4, article 3, Arizona Revised Statutes, is amended by adding
section 20-841.14, to read:

START_STATUTE
20-841.14.

Prostate cancer; high-risk patients; cost sharing; prohibition;
applicability; definition

A. A hospital service corporation or
medical service corporation that issues, amends or renews a subscription
contract on or after January 1, 2027 may not impose cost sharing requirements
for diagnostic prostate cancer screenings for high-risk subscribers.

b. This section does not apply to out-of-network
screenings.

c. For the purposes of this section,
"High-risk" includes
men who are at least forty
years of age and to whom any of the following
applies:

(
a
) are
of african ancestry.

(
b
) carry the
Breast cancer gene, including the BRCA1 or BRCA2 gene.

(
c
) have a
family history of prostate cancer. For the purposes of this subdivision,
"have a family history of prostate cancer" includes a first-degree
relative who:

(
i
) Was
diagnosed with prostate cancer
and who was under SIXTY
YEARS of age at the time of diagnosis.

(
ii
) Died of
prostate cancer.

(
iii
) Developed
a form of cancer that is known to be associated with an increased risk of
prostate cancer.

(
iv
) Was
diagnosed with a genetic mutation that is known to be associated with an
increased risk of prostate cancer.

(
d
) are
military veterans and have been exposed to agent orange.
END_STATUTE

Sec.
2.
2. Title
20, chapter 4, article 9, Arizona Revised Statutes, is amended by adding
section 20-1057.21, to read:

START_STATUTE
20-1057.21.

Prostate cancer; high-risk patients; cost sharing; prohibition;
applicability; definition

A. A health care services
organization that issues, amends or renews An evidence of coverage on or after
January 1, 2027 may not impose cost sharing requirements for diagnostic
prostate cancer screenings for high-risk enrollees.

b. This section does not apply to out-of-network
screenings.

c. For the purposes of this section,
"High-risk" includes
men who are at least forty
years of age and to whom any of the following
applies:

(
a
) are
of african ancestry.

(
b
) carry the
Breast cancer gene, including the BRCA1 or BRCA2 gene.

(
c
) have a
family history of prostate cancer. For the purposes of this subdivision,
"have a family history of prostate cancer" includes a first-degree
relative who:

(
i
) Was
diagnosed with prostate cancer
and who was under sixty
years of age at the time of diagnosis.

(
ii
) Died of
prostate cancer.

(
iii
) Developed
a form of cancer that is known to be associated with an increased risk of
prostate cancer.

(
iv
) Was
diagnosed with a genetic mutation that is known to be associated with an
increased risk of prostate cancer.

(
d
) are
military veterans and have been exposed to agent orange.
END_STATUTE

Sec.
3.
3. Title
20, chapter 6, article 4, Arizona Revised Statutes, is amended by adding
section 20-1376.11, to read:

START_STATUTE
20-1376.11.

Prostate cancer; high-risk patients; cost sharing; prohibition;
applicability; definition

A. A disability insurer that issues,
amends or renews a policy on or after January 1, 2027 may not impose cost
sharing requirements for diagnostic prostate cancer screenings for high-risk
insureds.

b. This section does not apply to out-of-network
screenings.

c. For the purposes of this section,
"High-risk" includes
men who are at least forty
years of age and to whom any of the following
applies:

(
a
) are
of african ancestry.

(
b
) carry the
Breast cancer gene, including the BRCA1 or BRCA2 gene.

(
c
) have a
family history of prostate cancer. For the purposes of this subdivision,
"have a family history of prostate cancer" includes a first-degree
relative who:

(
i
) Was
diagnosed with prostate cancer
and who was under sixty
years of age at the time of diagnosis.

(
ii
) Died of
prostate cancer.

(
iii
) Developed
a form of cancer that is known to be associated with an increased risk of
prostate cancer.

(
iv
) Was
diagnosed with a genetic mutation that is known to be associated with an
increased risk of prostate cancer.

(
d
) are
military veterans and have been exposed to agent orange.
END_STATUTE

Sec.
4.
4. Title
20, chapter 6, article 5, Arizona Revised Statutes, is amended by adding
section 20-1406.11, to read:

START_STATUTE
20-1406.11.

Prostate cancer; high-risk patients; cost sharing; prohibition;
applicability; definition

A. A group disability insurer or a
blanket disability insurer that issues, amends or renews a policy on or after
January 1, 2027 may not impose cost sharing requirements for diagnostic
prostate cancer screenings for high-risk insureds.

b. This section does not apply to out-of-network
screenings.

c. For the purposes of this section,
"High-risk" includes
men who are at least forty
years of age and to whom any of the following
applies:

(
a
) are
of african ancestry.

(
b
) carry the
Breast cancer gene, including the BRCA1 or BRCA2 gene.

(
c
) have a
family history of prostate cancer.� For the purposes of this subdivision,
"have a family history of prostate cancer" includes a first-degree
relative who:

(
i
) Was
diagnosed with prostate cancer
and who was under sixty
years of age at the time of diagnosis.

(
ii
) Died of
prostate cancer.

(
iii
) Developed
a form of cancer that is known to be associated with an increased risk of
prostate cancer.

(
iv
) Was
diagnosed with a genetic mutation that is known to be associated with an
increased risk of prostate cancer.

(
d
) are
military veterans and have been exposed to agent orange.
END_STATUTE